JCAD vs MedAdvisory
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
JCAD
This peer-reviewed medical journal provides dermatologists with up-to-date, evidence-based information on clinical and aesthetic dermatology. It features original research, practical discussions, comprehensive reviews, and commentaries from leading experts.
- Peer-reviewed publication
- Evidence-based information
- Original research
- Comprehensive reviews
- Expert editorial leadership
- Indexed on major databases
Read full descriptionHide full description
Journal of Clinical and Aesthetic Dermatology (JCAD) is a peer-reviewed publication that has already become an important addition to the field of dermatology. Under the expert editorial leadership of James Del Rosso, DO, and Philip Werschler, MD, JCAD provides dermatologists with up-to-date, evidence-based information that can be applied to their daily practices. JCAD offers its readers original research, practical discussion on the latest research, comprehensive reviews, didactic case reports, and provocative commentaries on contemporary topics relating to both clinical and aesthetic dermatology, written by key opinion leaders as well as practicing clinicians who are “in the trenches,” providing vital balance to the research-rich literature that is already available. JCAD is the official journal of the American Cutaneous Oncology Society and the American Acne and Rosacea Society. JCAD is indexed on PubMed Central, Scopus, EMBASE, and CINAHL Plus.
MedAdvisory
Facilitates real-time communication for gathering instant insights on drugs, diseases, tests, and treatments. This quick chat platform is ideal for market research, medical professionals, and students.
- Real-time communication
- Opinion leader insights
- Drug and disease discussions
- Test and trial data
- Diagnosis and treatment discussions
- Customizable chat platform
Read full descriptionHide full description
MedAdvisory is an iOS App, a one stop solution for real-time communication between internal & external stakeholders; gather instant Opinion Leader Inputs/insights on drugs and diseases, tests and trials, diagnosis and treatment, data and discussions in medicine. It is a Quick and easy chat platform for pharma or any other market research, students, doctors, others; customizable to match with company culture, image, reputation, branding
Screenshots
Verdict
The clearest difference is update cadence: MedAdvisory at every 8 days against JCAD's every 9 months. On price, rating, review sentiment and ratings volume there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 5.0 for JCAD against 5.0 for MedAdvisory. Both are backed by a comparable volume of ratings — 1 and 2 respectively. Written reviews split almost evenly too, at 100% and 100% positive.
JCAD ships an update every 9 months, MedAdvisory every 8 days. The most recent releases landed on September 30, 2026 and October 24, 2026 respectively.
| Parameter | JCAD | MedAdvisory |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) | 5.0 (2 ratings) |
| Positive reviews | 100.0% of reviews | 100.0% of reviews |
| Number of ratings | 1 | 2 — better |
| Update frequency | Every 9 months | Every 8 days — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 11.0 | 10.0 — better |
| Further details — not scored | ||
| Size | 87 MB | 94 MB |
| Age rating | 17+ | 12+ |
| Developer | Matrix Medical Communications | MedSphere Corp |
Customer experience
JCAD
MedAdvisory
In-app purchases
JCAD
No in-app purchases
MedAdvisory
No in-app purchases
